These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8946931

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL, Laliberté J, Eliopoulos N, Beauséjour C, Cournoyer D.
    Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999
    [Abstract] [Full Text] [Related]

  • 5. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358
    [Abstract] [Full Text] [Related]

  • 6. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL.
    Cancer Gene Ther; 2001 Sep 01; 8(9):669-76. PubMed ID: 11593336
    [Abstract] [Full Text] [Related]

  • 7. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
    Eliopoulos N, Bovenzi V, Le NL, Momparler LF, Greenbaum M, Létourneau S, Cournoyer D, Momparler RL.
    Gene Ther; 1998 Nov 01; 5(11):1545-51. PubMed ID: 9930308
    [Abstract] [Full Text] [Related]

  • 8. Assessment of resistance induction to cytosine arabinoside following transfer and overexpression of the deoxycytidylate deaminase gene in vitro.
    Schröder JK, Seidelmann M, Kirch HC, Seeber S, Schütte J.
    Leuk Res; 1998 Jul 01; 22(7):619-24. PubMed ID: 9680112
    [Abstract] [Full Text] [Related]

  • 9. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S, Lachmann N, Buchegger T, Hetzel M, Schambach A, Moritz T.
    J Exp Clin Cancer Res; 2015 Dec 12; 34():148. PubMed ID: 26651614
    [Abstract] [Full Text] [Related]

  • 10. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.
    Brennig S, Rattmann I, Lachmann N, Schambach A, Williams DA, Moritz T.
    Cytotherapy; 2012 Apr 12; 14(4):451-60. PubMed ID: 22242831
    [Abstract] [Full Text] [Related]

  • 11. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC, Schröder J, Hoppe H, Esche H, Seeber S, Schütte J.
    Exp Hematol; 1998 May 12; 26(5):421-5. PubMed ID: 9590659
    [Abstract] [Full Text] [Related]

  • 12. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM, Le NL, Létourneau S, Cournoyer D, Momparler RL.
    Hum Gene Ther; 1998 Nov 20; 9(17):2537-44. PubMed ID: 9853520
    [Abstract] [Full Text] [Related]

  • 13. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transfer of the cytidine deaminase cDNA into hematopoietic cells.
    Flasshove M, Frings W, Schröder JK, Moritz T, Schütte J, Seeber S.
    Leuk Res; 1999 Nov 15; 23(11):1047-53. PubMed ID: 10576510
    [Abstract] [Full Text] [Related]

  • 16. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL, Ravindranath Y, Matherly LH, Taub JW.
    J Natl Cancer Inst; 2005 Feb 02; 97(3):226-31. PubMed ID: 15687366
    [Abstract] [Full Text] [Related]

  • 17. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Feb 02; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 18. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A, Løvhaug D, Seeberg E, Nordlie EM.
    Exp Hematol; 1994 Feb 02; 22(2):208-14. PubMed ID: 7507861
    [Abstract] [Full Text] [Related]

  • 19. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N, Al-Khaldi A, Beauséjour CM, Momparler RL, Momparler LF, Galipeau J.
    Gene Ther; 2002 Apr 02; 9(7):452-62. PubMed ID: 11938460
    [Abstract] [Full Text] [Related]

  • 20. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 02; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.